1. What Protein G Recognizes
Protein G is an immunoglobulin-binding bacterial protein whose IgG-binding domains interact mainly with the Fc region. The binding site overlaps the general Fc area recognized by Protein A but differs in molecular contacts, producing different species and subclass preferences. That difference is the reason Protein G can capture some IgGs that bind Protein A weakly.
Native Protein G includes regions with functions beyond IgG binding, including albumin interaction. Recombinant purification ligands are commonly engineered to retain IgG-binding domains while removing albumin-binding regions. When reviewing a resin, confirm the ligand construct rather than assuming all Protein G media have identical specificity.
Because recognition is Fc-based, conventional intact IgG and compatible Fc-containing constructs are candidates. Fab and scFv fragments without Fc are not captured through the Protein G Fc interaction. Antibody aggregates or immune complexes may bind multivalently and elute differently from monomer.
2. Use Species and Subclass as a Screening Map
Often a strong reason to test Protein G
Mouse IgG1, human IgG3, and rat monoclonals are frequent examples where Protein G may offer broader or stronger capture than Protein A.
Often both A and G are plausible
Many human, rabbit, goat, sheep, and other mammalian IgGs can bind one or both ligands, with molecule-specific differences.
Require extra caution
Avian immunoglobulins, non-IgG isotypes, Fc-modified constructs, fragments, and poorly characterized wildlife antibodies may not follow common charts.
Do not turn this map into an absolute binding table. Species naming can conceal subclass diversity; recombinant antibodies may use constant regions from a different species than the original clone; and chimeric or humanized molecules should be classified by the Fc actually present.
3. Practical Interpretation by Source
| Antibody source | Why Protein G may be considered | What to verify |
|---|---|---|
| Human | Broad IgG binding, including human IgG3 where Protein A binding is often weaker | Subclass, Fc sequence, capacity, elution pH, and product quality |
| Mouse | Often favorable for mouse IgG1 and broad subclass capture | Exact clone/subclass, medium-derived immunoglobulins, and recovery |
| Rat | Protein G is commonly screened because several rat IgG subclasses bind usefully | Subclass and direct resin comparison; chart values vary by source |
| Rabbit | Rabbit IgG commonly binds both A and G | Whether Protein G offers a meaningful advantage in elution, purity, or cost |
| Goat or sheep | Protein G can capture IgG from these sources | Feed albumin/serum burden, binding strength, and ligand construct |
| Uncommon or wildlife species | Cross-species Fc conservation may permit binding | Direct screening with positive/negative controls; avoid extrapolation from related species |
4. Feed Type Changes the Decision
Hybridoma supernatant
Serum-free medium simplifies capture. Serum-containing medium can contribute bovine immunoglobulins and albumin, increasing competition and impurity burden. Even a recombinant Protein G ligand without albumin-binding domains cannot prevent all nonspecific or antibody-associated albumin from entering the pool. Compare culture-medium blank and antibody-containing feed.
Serum or plasma
Protein G can isolate total IgG, but the pool is polyclonal and heterogeneous. Stronger-binding species can displace weaker ones at high loading. If the goal is quantitative recovery of the natural repertoire, avoid overloading and compare subclass or antigen-reactivity distributions between feed and eluate.
Cell-culture feed for recombinant antibody
Clarify adequately and characterize titer, aggregates, host proteins, DNA, pH, conductivity, and viscosity. A Protein G step may be scientifically suitable yet economically less attractive than a well-established Protein A platform at large scale; compare total process performance and supply rather than assuming broader binding is better.
5. Run a Matched A-versus-G Screen
- Normalize the test. Use the same feed lot, resin volume, bed height or batch ratio, residence/contact time, temperature, and analytical methods.
- Measure binding. Analyze flow-through over increasing load; do not compare only final eluate yield.
- Develop wash. Determine whether serum proteins or host impurities can be removed without antibody loss.
- Map elution. Use a controlled pH screen and record fraction pH, concentration, monomer, aggregate, and activity.
- Close the mass balance. Include feed, flow-through, wash, eluate, and regeneration.
- Confirm under flow. Batch binding can rank candidates but does not establish DBC, pressure, or packed-bed recovery.
When one ligand binds more strongly, ask whether that strength is useful. A stronger interaction may increase capacity but require harsher elution. The best candidate maximizes acceptable recovered product, not retained mass.
6. Develop Binding, Washing, and Elution
Near-neutral buffers commonly support Protein G–IgG binding, but optimal pH and conductivity depend on antibody, ligand construct, and feed. Start within the antibody’s stability range. Measure dynamic capacity at relevant residence times and use a conservative operating load with margin for feed variability.
Wash first with binding buffer, then evaluate targeted conditions if impurities remain. Increased salt can reduce electrostatic associations; carefully selected additives may reduce other interactions. Every wash must be tested for antibody loss and downstream compatibility.
Acidic buffers commonly elute IgG from Protein G. Determine the least severe pH and shortest exposure that recover the antibody completely. Neutralize promptly unless an intentional low-pH hold is part of the process. Analyze monomer, aggregate, activity, and pool volume; a high UV peak does not demonstrate intact functional antibody.
7. Capacity, Pressure, and Format
Report Protein G DBC with the target, feed, residence time, bed height, and breakthrough criterion. Values measured with human polyclonal IgG can differ from a mouse monoclonal. Capacity also changes with particle/pore architecture and ligand density.
For research quantities, prepacked affinity cartridges reduce packing work. Loose resin provides flexible geometry and scale but requires bed qualification. Pressure-flow behavior should be measured in the most viscous expected buffer or feed and at operating temperature.
The site’s antibody affinity chromatography category includes media for antibody capture. Review the finished product specification rather than transferring conditions from a different Protein G resin.
8. Impurity and Product-Quality Controls
- Host or serum proteins: use target-specific and impurity-specific assays; total purity can hide low-level contaminants.
- Aggregate and fragments: compare feed and eluate because capture and low-pH handling can shift distributions.
- Ligand leakage: measure residual Protein G if relevant to intended use and track across cycles.
- Albumin: confirm whether the recombinant ligand lacks albumin-binding domains and still assess nonspecific or product-associated carryover.
- Biological activity: include antigen binding and Fc-dependent function when appropriate.
For polyclonal products, functional diversity may be more important than a single monomer percentage. Test whether purification changes antigen breadth or subclass composition.
9. Troubleshooting Protein G Capture
| Problem | Possible cause | Next check |
|---|---|---|
| Little or no binding | Wrong isotype/Fc, excessive load, short residence time, unfavorable buffer | Confirm construct and subclass; batch binding across pH; lower-flow packed test |
| Good binding, poor elution | Strong multivalent interaction, aggregate, insufficient elution strength | Fractionated pH screen and regeneration mass balance |
| Albumin-rich pool | Feed burden, product association, nonspecific adsorption, or ligand construct issue | Ligand documentation, blank-feed control, wash screen |
| Changing recovery across loads | Breakthrough or competitive displacement in heterogeneous feed | Full breakthrough curve and subclass/clone analysis |
| Aggregate after elution | Low pH, concentration, mixing, temperature, or pre-existing aggregate | Time-resolved stability and rapid-neutralization study |
10. Example: Selecting Capture for a Mouse IgG1
A mouse IgG1 is expressed in serum-free hybridoma medium. Parallel microscale tests show limited Protein A binding and strong Protein G binding. The Protein G candidate is then packed in a small column. DBC is measured at two residence times, followed by wash screening and a pH-step elution study.
The selected condition is not the lowest pH tested. A milder step gives slightly broader elution but higher monomer recovery and antigen-binding activity. Loading is set below the measured DBC to protect recovery across titer variation. An independent feed lot confirms the method before larger-scale use.
This example illustrates a decision path, not a universal mouse IgG1 protocol.
11. When Protein G Is Not the Best Choice
Protein G may bind an antibody well but still lose the overall workflow comparison. Protein A can offer a more established large-scale platform for a compatible Fc, while Protein L may capture an Fc-free compatible fragment. An antigen-specific ligand may provide functional selectivity, and ion exchange or another physicochemical method may be preferable when affinity elution damages the molecule.
Consider supply, ligand leakage, cleaning stability, resin cost, and available documentation alongside binding. For a one-time research preparation, a convenient prepacked Protein G device may be optimal even with modest capacity. For repeated industrial capture, productivity, lifetime, buffer demand, and polishing burden can dominate. Revisit the decision when the Fc sequence, expression system, medium, or required scale changes.
If Protein G captures the product but co-purifies serum immunoglobulins or related Fc-containing species, changing the wash may not create sufficient specificity. Upstream medium changes, antigen-affinity purification, or an orthogonal capture mechanism may solve the actual separation problem more effectively.
Test Protein G with the antibody that matters
We can support species/subclass screening, packed-bed confirmation, elution development, and antibody purification.
References
- Page M, Thorpe R. Protein A and Protein G purification of antibodies. Methods Mol Biol. 2019;1904:11–24. PMID:30602558.
- Carta G, Jungbauer A. Protein Chromatography: Process Development and Scale-Up. 2nd ed. 2020.
- Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol. 2007;7:715–725. (For Fc biology context; not a ligand-selection table.)
